AbbVie and Gilead Sciences each used the holiday season to reward their pipelines with a new clinical-stage cancer drug. | ...

Bevacizumab has been sold as Avastin by originator Roche for many years and used by the NHS for various forms of cancer, with ...

NDA supported by positive Phase II registration study data in Chinese patients; follows Breakthrough Therapy Designation granted in 2023 —— ...

According to a rumor that circulated online in late 2025, Speaker of the House Mike Johnson, R-La., gives away nearly all his ...

Several new laws in Virginia regarding social media, baby food, and healthcare take effect on January 1. Social media ...

AI is supposed to replace staff and reduce costs. Manuel Hofmann explains why these promises will not save the healthcare ...

When compiling our list of the best stocks to buy now, we look for high-quality companies that are poised to benefit over the ...

The human harms of cyberattacks piled up this year, and violence expected to increase The knock-on, and often unintentional, ...

Figure][1] Michael Teitell, MD, PhD Dr. Michael Teitell is the director of the UCLA Health Jonsson Comprehensive Cancer ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...

A recent study published in Engineering has shed light on the potential therapeutic effects of dihydrotanshinone I (DHT), a ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...